In a study that recruited NAFLD patients and healthy controls, the ratio of NE to AAT was higher in NAFLD patients and was closely associated with liver inflammation in patients with NASH, indicating that it can be used as a marker to evaluate the severity of NASH in humans (133). This evidence concerns the gene SERPINA1 and metabolic dysfunction-associated steatohepatitis.